Catalyst Wire Dossier Catalyst Wire Dossier

Nimacimab

Nimacimab · Skye Bioscience, Inc
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Nimacimab, covering 2020-01-18 to 2026-01-14. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo [Phase 2]

See pricing